About the topic: 

This event aims to facilitate a productive round-table discussion around good practice in licensing and commercialisation to improve transparency between the investor community, industry and TTOs, to better support emerging entrepreneurs.

Key points to be addressed include the level of equity level taken by universities in new ventures, and how this can often deter future investment, as well as important factors such as foreground and background IP.

We will also look at the positions of all parties involved in partnerships including students, postdocs, the universities themselves and industry, and what more is needed to help commercialise and scale this often-untapped innovation and ambition.  

Programme:

09.00  Guest arrival, breakfast and networking

09.30  Welcome by OBN & Penningtons Manches Cooper and keynote presentations from:

Dr Lisa Smith​, CEO of Midlands Mindforge​, an ambitious patient capital investment company, co-founded by eight research-intensive universities in the Midlands

Dr Michael Joseph​, Business Development Manager (Healthcare and Medtech) at Brunel University London​, who manages R&D and innovation partnerships in Healthcare and Medical Technology

10.00  Round table discussion between all guests

11.00  Event close

Event format: OBN's round table C-Suite Discussions are designed exclusively for senior leaders (C-Suite or equivalent) from life sciences organisations, whether R&D or those involved in providing critical support services to the industry. The purpose of these events is to generate some interesting, useful, high-level and boundary pushing discussion and debate, that creates some practical thought-leadership output.

Please note that places are limited and will be offered on an approval only basis.

This event is kindly hosted by Penningtons Manches Cooper at their offices at 125 Wood St, London EC2V 7AW